01 January 2001
Pseudomembranous colitis after eradication of Helicobacter pylori infection with a triple therapy
Igor Alexander Harsch, Eckhart Georg Hahn, Peter Christopher KonturekMed Sci Monit 2001; 7(4): CS751-754 :: ID: 421074
Abstract
BACKGROUND: H.pylori (H.p.) infection of the gastric mucosa is causallyrelated to chronic gastritis, peptic ulcer disease, MALT-lymphoma and gastric cancer. There is also anevidence for a link between the H.p.-infection and non-ulcer dyspepsia and even extragastric diseases.The number of patients treated against H.p. infection is expanding. Although in the last years the PPI-basedtriple therapies have been considered to be effective and safe, in some patients, however, severe side-effectsmay occur.
CASE REPORT: We report on a 86 year old female patient, who received a one-week triple eradicationtherapy (metronidazole 3x400 mg/die, clarithromycin 2x250 mg/die and omeprazole 2x20 mg/die) becauseof non-ulcer dyspepsia. A few days after the eradication treatment, she developed profuse watery andbloody diarrhea and abdominal pain with distention. In stool specimens Clostridium difficile toxin wasdetected. A colonoscopy showed typical features of antibiotic associated pseudomembranous colitis. Untilnow, only few reports concerning this complication have been published and the frequency of the complicationin patients eradicated for H.p. is unknown. The potential risk factors to develop this condition havenot been clarified. Since the complication may be potentially lethal, this severe side-effect of theusually well-tolerated triple-therapy has to be considered in patients suffering from profuse diarrheaand abdominal pain after eradication therapy.
Keywords: Helicobacter pylori, pseudomembranous colitis, clostridium difficile colitis, eradication
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Database Analysis
Risk Factors of Age-Related Macular Degeneration in a Population-Based Study: Results from SHIP-TREND-1 (St...Med Sci Monit In Press; DOI: 10.12659/MSM.943140
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952